Novo Nordisk's high government confronted a Senate grilling on Tuesday over the excessive costs of the corporate's weight reduction drug Wegovy and diabetes...
This yr's presidential election is already sending health-care shares on a wild journey. Traditionally, shifts in political management have created "elevated volatility" throughout...
